Cannabidiol (CBD) is a naturally occurring substance found in marijuana (Cannabis sativa). According to the Drug Enforcement Administration (DEA), CBD derived from the cannabis plant is a controlled substance under Schedule I of the Controlled Substances Act (CSA). Because it is a controlled substance, it cannot be used in products such as dietary supplements, foods, and vape oils (oils that are vaporized for inhalation). Furthermore, the Food and Drug Administration (FDA) recently stated that CBD products cannot be sold as dietary supplements because of the statutory definition of a dietary supplement.
Research into potential medical uses of CBD as a drug is ongoing for a number of health conditions, but at this time no FDA-approved drug products contain CBD. Anyone who plans to use/handle a controlled substance must obtain DEA registration. A registration is required to distribute, manufacture, prescribe, or test the substance for any use not provided under CSA.
The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that all drugs must be shown to be safe and effective for their intended use(s) before being marketed in the U.S. For more about FDA’s policies on CBD, read these Questions and Answers. In some states, however, state law permits certain patients to use CBD while under medical supervision.
For more about Cannabis sativa, please read the OPSS FAQ on hemp and military policy.
Updated 17 June 2016